Optimism is on the Rise with Biopharma Deal-Making Trends
By Marie Powers
Friday, April 26, 2013
CHICAGO This could be a very good year for deals, according to data from the Biotechnology Industry Organization (BIO) and biopharma consulting firm Campbell Alliance Group that were presented during a super session on structuring pipeline deals.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.